| Effects of nanomaterial physicochemical properties on in vivo toxicity KL Aillon, Y Xie, N El-Gendy, CJ Berkland, ML Forrest Advanced drug delivery reviews 61 (6), 457-466, 2009 | 950 | 2009 |
| Nanotechnology in vaccine delivery LJ Peek, CR Middaugh, C Berkland Advanced drug delivery reviews 60 (8), 915-928, 2008 | 698 | 2008 |
| Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment A Fakhari, C Berkland Acta biomaterialia 9 (7), 7081-7092, 2013 | 579 | 2013 |
| Nanoparticles for biomedical imaging SK Nune, P Gunda, PK Thallapally, YY Lin, M Laird Forrest, CJ Berkland Expert opinion on drug delivery 6 (11), 1175-1194, 2009 | 513 | 2009 |
| Precise control of PLG microsphere size provides enhanced control of drug release rate C Berkland, M King, A Cox, KK Kim, DW Pack Journal of controlled release 82 (1), 137-147, 2002 | 489 | 2002 |
| Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions C Berkland, KK Kim, DW Pack Journal of controlled release 73 (1), 59-74, 2001 | 463 | 2001 |
| Nanoparticle formulations in pulmonary drug delivery MM Bailey, CJ Berkland Medicinal research reviews 29 (1), 196-212, 2009 | 366 | 2009 |
| Microparticles K Kim, DW Pack, C Berkland US Patent 6,669,961, 2003 | 286* | 2003 |
| Practical considerations, challenges, and limitations of bioconjugation via azide–alkyne cycloaddition CJ Pickens, SN Johnson, MM Pressnall, MA Leon, CJ Berkland Bioconjugate chemistry 29 (3), 686-701, 2017 | 285 | 2017 |
| Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres C Berkland, MJ Kipper, B Narasimhan, KK Kim, DW Pack Journal of Controlled Release 94 (1), 129-141, 2004 | 281 | 2004 |
| PLG microsphere size controls drug release rate through several competing factors C Berkland, K Kim, DW Pack Pharmaceutical research 20, 1055-1062, 2003 | 277 | 2003 |
| Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering M Singh, C Berkland, MS Detamore Tissue Engineering Part B: Reviews 14 (4), 341-366, 2008 | 256 | 2008 |
| Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution C Raman, C Berkland, KK Kim, DW Pack Journal of Controlled Release 103 (1), 149-158, 2005 | 254 | 2005 |
| PLGA nanoparticle− peptide conjugate effectively targets intercellular cell-adhesion molecule-1 N Zhang, C Chittasupho, C Duangrat, TJ Siahaan, C Berkland Bioconjugate chemistry 19 (1), 145-152, 2008 | 241 | 2008 |
| ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells C Chittasupho, SX Xie, A Baoum, T Yakovleva, TJ Siahaan, CJ Berkland European journal of pharmaceutical sciences 37 (2), 141-150, 2009 | 222 | 2009 |
| Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects Q Wang, J Wang, Q Lu, MS Detamore, C Berkland Biomaterials 31 (18), 4980-4986, 2010 | 207 | 2010 |
| Biodegradable colloidal gels as moldable tissue engineering scaffolds Q Wang, L Wang, MS Detamore, C Berkland Advanced Materials 20 (2), 236-239, 2008 | 199 | 2008 |
| Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly (D, L-lactide-co-glycolide) C Berkland, DW Pack, KK Kim Biomaterials 25 (25), 5649-5658, 2004 | 196 | 2004 |
| Cell adhesion molecules for targeted drug delivery AL Dunehoo, M Anderson, S Majumdar, N Kobayashi, C Berkland, ... Journal of pharmaceutical sciences 95 (9), 1856-1872, 2006 | 182 | 2006 |
| NanoCipro encapsulation in monodisperse large porous PLGA microparticles MM Arnold, EM Gorman, LJ Schieber, EJ Munson, C Berkland Journal of Controlled Release 121 (1-2), 100-109, 2007 | 179 | 2007 |
Teruna SiahaanProfessor of Pharmaceutical Chemistry, The University of Kansas在 ku.edu 的电子邮件经过验证
